Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2022-03-25 Board/Management Inform…
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of outside directors (사외이사). This falls under the category of board and management changes, specifically the appointment of directors.
2022-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal submission of an audit report ('감사보고서 제출') by Il-Sung Pharmaceuticals. It provides the audit opinion, financial highlights (assets, liabilities, profit/loss), and the name of the accounting firm. While it contains financial data, it is a standalone audit disclosure rather than a full annual report (10-K) or an earnings release. According to the filing definitions, standalone audit reports and results of internal audits fall under the 'AR' category. FY 2021
2022-03-17 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Il-Sung Pharmaceutical Co., Ltd. for the fiscal year ending December 31, 2021. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it lacks the broader management discussion and analysis (MD&A) or business overview typical of a full 10-K, and it is not a mere announcement (RPA) due to its significant length and inclusion of full financial statements. FY 2021
2022-03-17 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (AGM) for Il-Sung Pharmaceuticals, specifically detailing the agenda items, board member nominations, and the resolution of the board of directors. It is a regulatory filing related to the convocation of a shareholder meeting, which falls under the Proxy Solicitation & Information Statement category as it provides shareholders with the necessary information to vote on agenda items.
2022-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Ilsung Pharmaceuticals. It details the meeting agenda, including financial statement approval, director appointments, and dividend proposals. This document is a formal proxy statement sent to shareholders to provide information and request votes for the upcoming AGM, which fits the definition of a Proxy Solicitation & Information Statement.
2022-03-10 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Il-Sung Pharmaceutical. It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and appointment of audit committee members. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2022-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.